Targeted Strategies for Today's Evolving Markets

MissionIR Blog

BioDelivery Sciences International, Inc. (BDSI) Starts Presentation at 25th Annual ROTH Conference

Posted on March 18, 2013 by Mission IR

BioDelivery Sciences International is a specialty pharmaceutical company leveraging its novel and proprietary patented drug delivery technologies to develop and commercialize new applications of proven therapeutics – either independently or in partnerships with third parties. The company is currently focused on developing products to meet unmet patient needs in pain management and addiction, and its pain franchise presently consists of two products utilizing the patented BEMA technology: ONSOLIS and BEMA Buprenorphine, both in Phase 3 clinical development. For more information, visit the company’s Web site: http://www.bdsi.com

Let us hear your thoughts below:

This year's annual ROTH Conference will take place at The Ritz Carlton located in Laguna Niguel, on March 17-12, 2013. Bringing together executives from more than 400 growth companies, the ROTH Conference is one of the largest of its kind in the U.S. For more information on ROTH Capital Partners, visit www.roth.com.
This entry was posted in ROTH Capital Partners Conference. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *